A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
Takeda
Alliance for Clinical Trials in Oncology
Pfizer
Second Affiliated Hospital of Guangzhou Medical University
Massachusetts General Hospital
Massachusetts General Hospital
Quadriga Biosciences, Inc.
Xencor, Inc.
ImmVira Pharma Co. Ltd
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Memorial Sloan Kettering Cancer Center
University of Chicago
National Cancer Institute (NCI)
Memorial Sloan Kettering Cancer Center
Mannkind Corporation